XIAFLEX ® is a registered trademark of Endo International plc or one of its affiliates. © 2021 Endo Pharmaceuticals Inc. All rights reserved. Malvern, PA 19355 Privacy/Legal MULTI-05162/August 2019 www.xiaflex.com 1-800-462-ENDO (3636), 10/25/2019 · DUBLIN, Oct. 25, 2019 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX ® (collagenase clostridium histolyticum) for the treatment of Peyronie’s disease will be presented as poster presentations at the 20 th Annual Fall Meeting of the Sexual Medicine Society of North America (SMSNA) in Nashville, TN, October 24 – 27, 2019.
XIAFLEX should be administered by a healthcare provider experienced in injection procedures of the hand and in the treatment of patients with Dupuytren’s contracture. XIAFLEX, supplied as a lyophilized powder, must be reconstituted with the provided diluent prior to.
10/19/2020 · Under the terms of the relationship, BioSpecifics receives a royalty stream from Endo related to Endo’s collagenase-based therapies, which currently include XIAFLEX®, marketed by Endo Pharmaceuticals, for the treatment of Dupuytren’s contracture and Peyronie’s disease, and Qwo™, the first FDA-approved injectable treatment for cellulite, which is expected to be launched by Endo .
9/5/2019 · Endo to Present New XIAFLEX ® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand’s (ASSH) Annual Meeting. DUBLIN, Sept. 5, 2019 /PRNewswire/ — Endo …
British Dupuytren’s Society: Xiapex to be discontinued, Access and reimbursement | XIAFLEX® (collagenase …
British Dupuytren’s Society: Xiapex to be discontinued, XIAFLEX® (collagenase clostridium histolyticum), XIAFLEX ®. XIAFLEX ® has been made available in Australia and New Zealand pursuant to an agreement between Actelion and Endo Ventures Limited and has been distributed in New Zealand by Health Care Logistics on behalf of Actelion. It has provided a non-surgical option for patients with Dupuytren’s Contracture and Peyronie’s Disease.
XIAFLEX® is a registered trademark of Endo International plc or one of its affiliates. © 2020 Endo Pharmaceuticals Inc. All rights reserved. Malvern, PA 19355 MM-05525/July 2020 www.xiaflex.com 1-800-462-ENDO (3636) Rx Only INDICATION, Endo Pharmaceuticals works to make treatment more affordable for all eligible patients. If you are ordering XIAFLEX ® through a Specialty Distributor, remind your eligible patients to complete the XIAFLEX ® Copay Program Reimbursement Form If your patient is uninsured, have them apply to our Patient Assistance Program
